Determining Risk of Relapse After Bone Marrow Transplant Among Patients With AML
Posted: 03/20/2023 | By: Chase Doyle

Researchers have found that screening for residual disease prior to a bone marrow transplant using a blood test may help physicians identify which adult patients in remission from acute myeloid leukemia (AML) are at risk of relapsing after the procedure, according to a novel study published by Dillon et al in JAMA.

Question 1 of 5

What is the most common indication for allogeneic hematopoietic cell transplant in adults with acute myeloid leukemia (AML) in first remission?

Choose 1